Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 3/20 | 0.72 |
| ▸ | MEN1 | O00255 | 3/20 | 0.72 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.72 |
| ▸ | GLA | P06280 | 1/20 | 0.72 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.68 |
| ▸ | CA12 | O43570 | 5/20 | 0.67 |
| ▸ | CA6 | P23280 | 5/20 | 0.67 |
| ▸ | CA7 | P43166 | 5/20 | 0.67 |
| ▸ | CA9 | Q16790 | 5/20 | 0.67 |
| ▸ | CA14 | Q9ULX7 | 5/20 | 0.67 |
| ▸ | CA5B | Q9Y2D0 | 5/20 | 0.67 |
| ▸ | CA2 | P00918 | 4/20 | 0.67 |
| ▸ | CA4 | P22748 | 4/20 | 0.67 |
| ▸ | CA5A | P35218 | 4/20 | 0.67 |
| ▸ | CA3 | P07451 | 3/20 | 0.67 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.61 |
| ▸ | LMNA | P02545 | 2/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.61 |
| ▸ | CA1 | P00915 | 2/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23936863 | 0.97 | CYP2C19 (0.77) | CYP2C19MEN1KMT2AGLACYP1A2 | |
| Ammonia Solution, Strong SCHEMBL3073269 | 0.94 | CYP2C19 (0.72) | CYP2C19MEN1KMT2AGLACYP1A2 | |
| SCHEMBL1247701 | 0.94 | CA12 (0.69) | CYP2C19MEN1KMT2AGLACYP1A2 | |
| SCHEMBL911151 | 0.94 | — | — | |
| SCHEMBL10081836 | 0.94 | CA12 (0.69) | CYP2C19MEN1KMT2AGLACYP1A2 | |
| SCHEMBL18427300 | 0.94 | CA12 (0.69) | CYP2C19MEN1KMT2AGLACYP1A2 | |
| SCHEMBL878956 | 0.94 | CA12 (0.69) | CYP2C19MEN1KMT2AGLACYP1A2 | |
| SCHEMBL29753241 | 0.92 | CYP2C19 (0.68) | CYP2C19MEN1KMT2AGLACYP1A2 | |
| SCHEMBL29054916 | 0.92 | CYP2C19 (0.68) | CYP2C19MEN1KMT2AGLACYP1A2 | |
| Ammonia Solution, Strong SCHEMBL3076469 | 0.92 | CA12 (0.65) | CYP2C19MEN1KMT2AGLACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170137553-A1 | GRAFT POLYMER, RESIN COLORED MATTER, METHOD FOR PRODUCING SAME, AND RESIN COMPOSITION CONTAINING RESIN COLORED MATTER | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2017-05-18 | — | — | US | disclosed |
| US-9468650-B2 | Inhibition of endosomal toll-like receptor activation | DUKE UNIVERSITY (US) | 2016-10-18 | — | — | US | disclosed |
| US-8143413-B2 | Polycationized phospholipid derivatives | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2012-03-27 | — | — | US | disclosed |
| US-20100094020-A1 | POLYCATIONIZED PHOSPHOLIPID DERIVATIVES | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2010-04-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100094020-A1 | POLYCATIONIZED PHOSPHOLIPID DERIVATIVES | PHOSPHO1, PLTP, PTDSS2 | CYP2C19 4322/4885MEN1 2015/4885KMT2A 2297/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.